Three Damon Runyon alumni elected to the National Academy of Medicine
Share
The National Academy of Medicine provides independent, evidence-based scientific advice to address national and global health challenges. Membership is considered to be one of the highest honors in the medical field and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. This year, three Damon Runyon alumni were nominated for membership, bringing the total number of Damon Runyon scientists in the organization to 49.
Omar Abdel-Wahab, MD (Damon Runyon Clinical Investigator ’13-’16), of Memorial Sloan Kettering Cancer Center in New York, is recognized “for being a pioneer in uncovering genetic causes for diverse forms of blood cancers and utilizing this information to develop therapeutic approaches to transform clinical care.”
Wendy S. Garrett, MD, PhD (Damon Runyon Fellow ’06-’09), of Harvard T.H. Chan School of Public Health in Boston, is recognized “for her research into microbiomes in inflammatory bowel diseases, intestinal immunity, kidney disease, and colorectal cancer that has advanced the understanding of microbiome-host interactions and how microbial metabolites shape immune system function in health and disease.”
David G. Kirsch, MD, PhD (Damon Runyon-Rachleff Innovator ’08-’10), of Princess Margaret Cancer Centre in Toronto, is recognized “for developing innovative genetically engineered mouse models of sarcoma to elucidate biological mechanisms of sarcoma development, metastasis, and response to radiotherapy and immunotherapy.”
Read the full press release here.
Share
